Updated Jul 16, 2026
Hatfield Jeffrey S. has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Jeffrey S. Hatfield is listed as a director of Vir Biotechnology, Inc. in the context of SEC filings dated 2026-05-28. The available context provides no further details about his education, career history, or other board memberships. There is no indication within the provided context that he is deceased.
| Role | Director |
|---|---|
| Notability | 45/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-28 | VIR | Vir Biotechnology, Inc. | A — Grant or award | 8.0K | $0.00 |
Jeffrey S. Hatfield is listed as a director of Vir Biotechnology, Inc. in the context of SEC filings dated 2026-05-28. The available context provides no further details about his education, career history, or other board memberships. There is no indication within the provided context that he is deceased.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Hatfield Jeffrey S. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.